Long-term evaluation follow-up of neurocognitive performance and emotional state in patients with chronic hepatitis C infection and a former (Peg)interferon alfa-2b-based therapy

Trial Profile

Long-term evaluation follow-up of neurocognitive performance and emotional state in patients with chronic hepatitis C infection and a former (Peg)interferon alfa-2b-based therapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Oct 2009

At a glance

  • Drugs Peginterferon alfa-2b (Primary)
  • Indications Hepatitis C
  • Focus Pharmacodynamics
  • Most Recent Events

    • 13 Oct 2009 Actual patient number (197) added as reported by ClinicalTrials.gov.
    • 13 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top